5.0 based on 8 reviewsView this provider's reviews
Patient satisfaction ratings and reviews are based on personal opinions. Before you choose any doctor you should take into account their background, training, specialized experience AND their patient satisfaction to ensure they are the right fit for you.
Accepting new patients
Dr. Christopher Barbieri, MD is an urologic oncology specialist in New York, NY and has been practicing for 4 years. He specializes in urologic oncology and urology.Read his story
This content was provided by Dr. Barbieri "Dr. Christopher Barbieri completed both his Urology Residency and Urologic Oncology Fellowship at Weill Cornell Medical College. He received his undergraduate degree from Dartmouth College and then attended Vanderbilt University School of Medicine, where he obtained both his MD and PhD degrees. Dr. Barbieri's research interests include using genomic data to define distinct molecular subclasses of urologic malignancy, with a particular focus on prostate cancer. His work has led to recognition as a Prostate Cancer Foundation Young Investigator and a Urology Care Foundation Research Scholar; he is also the recipient of a Career Development Award from the National Cancer Institute to fund his work on prostate cancer. In addition, Dr. Barbieri has also been recognized as a Rising Star in Urology Research by the American Urological Association, and with a Clinical Investigator Award from the Damon Runyon Cancer Research Foundation."
This content was provided by Dr. Barbieri "Prostate cancer is a disease with highly variable outcomes - many patients have slow growing cancers that will never threaten their health, while other have aggressive cancers that may rapidly progress. A variety of new tools are available to help urologists match the right patient with the right treatment course, from cutting edge tests exposing the molecular basis of these cancers to imaging techniques that can allow precise targeting of cancers. A urologist that understands the use and limitations of these tools is critical to get the best outcomes. I am both a prostate cancer surgeon and a highly active researcher in prostate cancer genomics in the Sandra and Edward Meyer Cancer Center at Weill Cornell, allowing me to stay at the forefront of prostate cancer care in the 21st century, and delivering the best possible care to patients at Weill Cornell."